Study analyzes diabetes drug metformin as obesity treatment for children

December 16, 2013

Treatment with the diabetes drug metformin appears to be associated with a modest reduction in body mass index (BMI) in obese children when combined with lifestyle interventions such as diet and exercise, according to a study by Marian S. McDonagh, Pharm. D., of the Oregon Health & Science University, and colleagues.

Childhood obesity is a health problem in the United States, with nearly 17 percent of children being obese. Metformin is approved by the Food and Drug Administration to treat type 2 diabetes in adults and children over 10 years old, but it has been used off-label in recent years to treat childhood obesity.

Researchers assessed the safety and effectiveness of metformin to treat obesity in children (ages 18 and younger) without a diagnosis of diabetes by reviewing results from 14 clinical trials. The trials included 946 children and adolescents, who ranged in age from 10 to 16 years, and had baseline BMIs from 26 to 41.

The results indicated that while metformin helped obese children reduce their BMI (a reduction of -1.38 from baseline) and weight compared with lifestyle interventions alone, the change was small compared to what is needed for long-term health benefits. Researchers noted no serious adverse events were reported.

"While our results indicate that some and adolescents may benefit from short-term treatment with metformin combined with , these benefits were very modest, not achieving a 5 percent reduction in BMI," the study concludes.

Explore further: Metformin improves blood glucose levels and BMI in very obese children

More information: JAMA Pediatr. Published online December 16, 2013. DOI: 10.1001/jamapediatrics.2013.4200

Related Stories

Metformin treatment beneficial for obese children, teens

December 21, 2012

(HealthDay)—Obese children and adolescents treated with twice-daily metformin have significantly improved body mass index standard deviation scores (BMI-SDS), fasting glucose, and other metabolic risk factors, according ...

2 drugs better than 1 to treat youth with type 2 diabetes

April 29, 2012

A combination of two diabetes drugs, metformin and rosiglitazone, was more effective in treating youth with recent-onset type 2 diabetes than metformin alone, a study funded by the National Institutes of Health (NIH) has ...

Recommended for you

Diagnosing fetal alcohol disorder more easily

October 17, 2016

Early-childhood clinicians such as pediatricians and child psychologists are often the first to raise the alarm for families with children who exhibit developmental disorders, such as fetal alcohol spectrum disorder (FASD). ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.